Protein Summary
Functions as cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades. Plays a role in the activation of ITGB1 and integrin signaling, leading to the activation of AKT, FAK/PTK2 and MAP kinases. Promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of AKT and FAK/PTK2. Plays a role in VEGFA signaling via its role in regulating the internalization of KDR/VEGFR2. Plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the PMEL luminal domain that is essential for the development and maturation of melanocytes. Plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of SELP trafficking. May play a role in mast cell degranulation in response to Ms4a2/FceRI stimulation, but not in mast cell degranulation in response to other stimuli. The protein encoded by this gene is a member of th ...more
- ENST00000257857
- ENSP00000257857
- ENSG00000135404
- ENST00000420846
- ENSP00000393502
- ENST00000546939
- ENSP00000447356
- ENST00000549117
- ENSP00000447730
- ENST00000550776
- ENSP00000448091
- ENST00000552692
- ENSP00000449337
- ENST00000552754
- ENSP00000446807
- MLA1
- TSPAN30
- MLA1
- ME491
- LAMP-3
- OMA81H
- TSPAN30
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
disease perturbation | 1 | ||
kinase perturbation | 0.95 | ||
PubMedID | 0.86 | ||
disease | 0.85 | ||
transcription factor binding site profile | 0.76 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1861.74 (req: < 5)
Gene RIFs: 100 (req: <= 3)
Antibodies: 1768 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 1861.74 (req: >= 5)
Gene RIFs: 100 (req: > 3)
Antibodies: 1768 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 14
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 11
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0